Vaccination ＆ CDS Subsidies

The National Adult Immunisation Schedule (NAIS) was established in November 2017 to provide guidance on vaccinations that persons age 18 years or older should adopt to protect themselves against vaccine-preventable diseases. The overall recommendations for adult vaccinations in the NAIS remain the same since its inception in November 2017. Minor changes have been made to clarify existing recommendations, which are reflected in the updated schedule in Table 1.

From 1 November 2020, in addition to chronic obstructive pulmonary disease (COPD), the CDMP/CHAS Chronic conditions for which influenza vaccination is claimable will be expanded to include diabetes, hypertension, lipid disorders, asthma, chronic kidney disease (CKD), and ischaemic heart disease (IHD), in line with NAIS guidelines on the recommended groups for seasonal influenza vaccination.

Table 1: NAIS

Please refer to MOH CIRCULAR No 182/2020 Updates to the National Adult Immunisation Schedule for more information. 

Subsidies framework for vaccination in the NAIS:
From 1 November 2020, Singaporean adults will receive means-tested subsidy for all NAIS vaccinations where the vaccine utilised is found on the Subsidised Vaccine List (SVL).

Use of Medisave for vaccination in the NAIS:
MediSave-accredited providers can continue to submit MediSave claims for the remaining out-of-pocket cost of recommended vaccinations under NAIS under the MediSave500 scheme. Patients aged 60 and above can also tap on Flexi-MediSave.

Please refer to MOH FCM No. 41/2020  Extension of Subsidies for Nationally Recommended Vaccinations and Childhood Developmental Screening (CDS) at All Community Health Assist Scheme (CHAS) GP Clinics  for more information.